Lung function parameters in omalizumab responder patients: An interesting tool?

Allergy
F PaganinL Guilleminault

Abstract

Omalizumab, an anti-IgE antibody, is used to treat patients with severe allergic asthma. The evolution of lung function parameters over time and the difference between omalizumab responder and nonresponder patients remain inconclusive. The objective of this real-life study was to compare the changes in forced expiratory volume in 1 second (FEV1) of omalizumab responders and nonresponders at 6 months. A multicenter analysis was performed in 10 secondary and tertiary institutions. Lung function parameters (forced vital capacity (FVC), pre- and postbronchodilator FEV1, residual volume (RV), and total lung capacity (TLC) were determined at baseline and at 6 months. Omalizumab response was assessed at the 6-month visit. In the omalizumab responder patients, lung function parameters were also obtained at 12, 18, and 24 months. Mean prebronchodilator FEV1 showed improvement in responders at 6 months, while a decrease was observed in nonresponders (+0.2±0.4 L and -0.1±0.4 L, respectively, P<.01). After an improvement at 6 months, pre- and postbronchodilator FEV1 remained stable at 12, 18, and 24 months. The FEV1/FVC remained unchanged over time, but the proportion of patients with an FEV1/FVC ratio <0.7 decreased at 6, 12, 18, and 24 m...Continue Reading

References

Feb 1, 1994·American Journal of Respiratory and Critical Care Medicine·P L EnrightD W Cockroft
Sep 1, 2001·The European Respiratory Journal·M SolèrG Della Cioppa
Feb 11, 2004·Current Allergy and Asthma Reports·Nicola Scichilone, Alkis Togias
Apr 15, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S T HolgateUNKNOWN Omalizumab 011 International Study Group
Nov 3, 2005·The European Respiratory Journal·R PellegrinoJ Wanger
May 16, 2008·American Journal of Respiratory and Critical Care Medicine·Pranab HaldarRuth H Green
Nov 7, 2009·American Journal of Respiratory and Critical Care Medicine·Wendy C MooreUNKNOWN National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Mar 12, 2011·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Elisabetta PaceMark Gjomarkaj
Jul 12, 2011·The Clinical Respiratory Journal·Christian SchumannClaus Kroegel
Dec 14, 2011·Pulmonary Pharmacology & Therapeutics·Eleni G TzortzakiNikolaos M Siafakas
Jan 10, 2012·Respiratory Care·Gregg L Ruppel, Paul L Enright
Mar 27, 2012·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·María Del Carmen VenneraUNKNOWN Spanish Registry
Oct 18, 2012·Pulmonary Pharmacology & Therapeutics·Nicola ScichiloneNicola Sverzellati
Dec 18, 2013·The European Respiratory Journal·Kian Fan ChungW Gerald Teague
Mar 1, 1993·The European Respiratory Journal·P H QuanjerJ C Yernault
May 2, 2014·Allergologia et immunopathologia·J Jesús López TiroD Larenas Linnemann
Jul 6, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Tomoko TajiriMichiaki Mishima
Sep 18, 2014·Allergy, Asthma & Immunology Research·Omar S Usmani
Nov 15, 2014·International Journal of Clinical Pharmacy·Caroline GouderStephen Montefort
Nov 25, 2014·Health and Quality of Life Outcomes·Lieke Schiphof-GodartThys van der Molen
Dec 3, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Michael Schatz, Lanny Rosenwasser
Dec 22, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Leslie HendelesMutasim Abu-Hasan
Oct 7, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Robert S ZeigerAniket A Kawatkar
Jan 15, 2016·Biomarkers in Medicine·Tracy L StatonJoseph R Arron

❮ Previous
Next ❯

Citations

May 8, 2018·Immunity, Inflammation and Disease·S Gunnar O JohanssonAnna Nopp
Apr 20, 2019·Therapeutic Advances in Respiratory Disease·Paolo SolidoroCaterina Bucca
Dec 2, 2018·Clinical and Translational Allergy·J BousquetI Agache
Nov 27, 2020·Clinical Reviews in Allergy & Immunology·Russell J HoppM Asghar Pasha
Jan 26, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Nicola A HananiaBradley E Chipps
Dec 15, 2020·Expert Review of Clinical Immunology·Kenneth M FaulknerChristopher S Lee
Jan 25, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Jean BousquetFrancis Nissen
Dec 24, 2019·Revue des maladies respiratoires·T Villeneuve, L Guilleminault
Jun 26, 2021·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Arabelle Abellard, Andrea A Pappalardo
Jul 25, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Stanley J SzeflerGolda Hudes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.